Do Potassium Binders Block Both the Benefits and the Risks of Mineralocorticoid Receptor Antagonists in Heart Failure? The Four Anti-Aldosterone Myths

被引：1

作者：

Packer, Milton ^{[1
,2
]}

机构：

[1] Baylor Heart & Vasc Inst, Dallas, TX USA

[2] Imperial Coll, London, England

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2025年 / 85卷 / 10期

关键词：

guideline-directed medical therapy; heart failure; hyperkalemia; mineralocorticoid receptor antagonists; sodium zirconium cyclosilicate; EPLERENONE;

D O I：

10.1016/j.jacc.2025.01.011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：985 / 987

页数：3

共 10 条

[1] Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial [J].

Butler, Javed ;

Anker, Stefan D. ;

Lund, Lars H. ;

Coats, Andrew J. S. ;

Filippatos, Gerasimos ;

Siddiqi, Tariq Jamal ;

Friede, Tim ;

Fabien, Vincent ;

Kosiborod, Mikhail ;

Metra, Marco ;

Pina, Ileana L. ;

Pinto, Fausto ;

Rossignol, Patrick ;

van der Meer, Peter ;

Bahit, Cecilia ;

Belohlavek, Jan ;

Boehm, Michael ;

Brugts, Jasper J. ;

Cleland, John G. F. ;

Ezekowitz, Justin ;

Bayes-Genis, Antoni ;

Gotsman, Israel ;

Goudev, Assen ;

Khintibidze, Irakli ;

Lindenfeld, Joann ;

Mentz, Robert J. ;

Merkely, Bela ;

Montes, Eliodoro Castro ;

Mullens, Wilfried ;

Nicolau, Jose C. ;

Parkhomenko, Aleksandr ;

Ponikowski, Piotr ;

Seferovic, Petar M. ;

Senni, Michele ;

Shlyakhto, Evgeny ;

Cohen-Solal, Alain ;

Szecsody, Peter ;

Jensen, Klaus ;

Dorigotti, Fabio ;

Weir, Matthew R. ;

Pitt, Bertram .

EUROPEAN HEART JOURNAL, 2022, 43 (41) :4362-4373

[2] Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril A Secondary Analysis of the PARADIGM-HF Trial [J].

Desai, Akshay S. ;

Vardeny, Orly ;

Claggett, Brian ;

McMurray, John J. V. ;

Packer, Milton ;

Swedberg, Karl ;

Rouleau, Jean L. ;

Zile, Michael R. ;

Lefkowitz, Martin ;

Shi, Victor ;

Solomon, Scott D. .

JAMA CARDIOLOGY, 2017, 2 (01) :79-85

[3] The Association of Heart Failure and Edema Events between Patients Initiating Sodium Zirconium Cyclosilicate or Patiromer [J].

Desai, Nihar R. ;

Kammerer, Jennifer ;

Budden, Jeffrey ;

Olopoenia, Abisola ;

Tysseling, Asa ;

Gordon, Alexandra .

KIDNEY360, 2024, 5 (12) :1835-1843

[4] Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled [J].

Ferreira, Joao Pedro ;

Zannad, Faiez ;

Butler, Javed ;

Filipattos, Gerasimos ;

Ritter, Ivana ;

Schuler, Elke ;

Kraus, Bettina J. ;

Pocock, Stuart J. ;

Anker, Stefan D. ;

Packer, Milton .

EUROPEAN HEART JOURNAL, 2022, 43 (31) :2984-2993

[5] Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS-HF trial [J].

Ferreira, Joao Pedro ;

Abreu, Paula ;

McMurray, John J. V. ;

van Veldhuisen, Dirk J. ;

Swedberg, Karl ;

Pocock, Stuart J. ;

Vincent, John ;

Lins, Katharina ;

Rossignol, Patrick ;

Pitt, Bertram ;

Zannad, Faiez .

EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (03) :345-351

[6] Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways? [J].

Hermidorff, Milla Marques ;

Faria, Gabriela de Oliveira ;

Sousa Amancio, Gabriela de Cassia ;

Monteiro de Assis, Leonardo Vinicius ;

Isoldi, Mauro Cesar .

BIOCHEMISTRY AND CELL BIOLOGY, 2015, 93 (01) :83-93

[7] Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients With Heart Failure [J].

Kosiborod, Mikhail N. ;

Cherney, David Z. I. ;

Desai, Akshay S. ;

Testani, Jeffrey M. ;

Verma, Subodh ;

Chinnakondepalli, Khaja ;

Dolling, David ;

Patel, Shachi ;

Dahl, Magnus ;

Eudicone, James M. ;

Friberg, Lovisa ;

Ouwens, Mario ;

Antunes, Murillo O. ;

Connelly, Kim A. ;

Madrini, Vagner ;

Kuthi, Luca ;

Lala, Anuradha ;

Lorenzo, Miguel ;

Guimaraes, Patricia O. ;

Marcos, Marta Cobo ;

Merkely, Bela ;

Nunez, Julio ;

Squire, Iain ;

Vaclavik, Jan ;

Wranicz, Jerzy ;

Petrie, Mark C. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (10) :971-984

[8]

KRISHNA GG, 1987, J LAB CLIN MED, V109, P724

[9] Potassium binders for patients with heart failure? The real enlightenment of the DIAMOND trial [J].

Packer, Milton .

EUROPEAN HEART JOURNAL, 2022, 43 (41) :4374-4377

[10] Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure [J].

Pitt, B ;

White, H ;

Nicolau, J ;

Martinez, F ;

Gheorghiade, M ;

Aschermann, M ;

van Veldhuisen, DJ ;

Zannad, F ;

Krum, H ;

Mukherjee, R ;

Vincent, J .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (03) :425-431

← 1 →